Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer

Clinica Chimica Acta

Volumn 357, Issue 2, 2005, Pages 190-195

  Stavropoulou, Panagiota ^a   Gregorakis, Alkiviades K ^a   Plebani, Mario ^b   Scorilas, Andreas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Free PSA; Kallikreins; PCR; Prostate; Prostate cancer; Prostate specific antigen; PSA; Serine proteases; Tumor biomarkers

Indexed keywords

AGAROSE; ETHIDIUM BROMIDE; KALLIKREIN; KALLIKREIN 11; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 21244433450     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.03.026     Document Type: Article

References (31)

1. A. Scorilas, H. Yu, A. Soosaipilai, A. Gregorakis, and E.P. Diamandis Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy Clin Chim Acta 292 2000 127 138
2. G.M. Yousef, A. Chang, A. Scorilas, and Eleftherios P. Diamandis Genomic organization of the human kallikrein locus on chromosome 19q13.3-q13.4 Biochem Biophys Res Commun 276 2000 125 133
3. G.M. Yousef, and E.P. Diamandis The new human tissue kallikrein gene family: structure, function and association to disease Endocr Rev 22 2001 184 204
4. R.B. Sim, and A. Laich Serine proteases of the complement system Biochem Soc Trans 28 2000 545 550
5. A. Scorilas, C.A. Borgono, N. Harbeck, J. Dorn, B. Schmalfeldt, and M. Schmitt Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker J Clin Oncol 22 2004 678 685
6. G.M. Yousef, and E.P. Diamandis Tissue kallikreins: new players in normal and abnormal cell growth? Thromb Haemost 90 2003 7 16
7. C. Stephan, K. Jung, E.P. Diamandis, H.G. Rittenhouse, M. Lein, and S. Loening Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer Urology 59 2002 2 8
8. A. Scorilas, M. Plebani, S. Mazza, D. Basso, A.R. Soosaipillai, and N. Katsaros Serum human glandular kallikrein (hk2) and insulin-like growth factor I (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA The Prostatez 9999 2002 1 10
9. T. Nakamura, A. Scorilas, C. Stephan, K. Jung, R. Antoninus, and A. Soosaipillai The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia Cancer Res 63 2003 6543 6546
10. S. Yoshida, M. Taniguchi, T. Suemoto, T. Oka, X. He, and S. Shiosaka cDNA cloning and expression of a novel serine protease, TLSP Biochim Biophys Acta 1399 1998 225 228
11. G.M. Yousef, A. Scorilas, and E.P. Diamandis Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family Genomics 63 2000 88 96
12. S. Mitsui, T. Yamada, A. Okui, K. Kominami, H. Uemura, and N. Yamaguchi A novel isoform of a kallikrein-like protease, TLSP/Hippostasin, (PRSS20), is expressed in the human brain and prostate Biochem Biophys Res Commun 272 2000 205 211
13. T. Nakamura, S. Mitsui, A. Okui, K. Kominami, T. Nomoto, and O. Ukimura Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines The Prostate 49 2001 72 78
14. T. Nakamura, S. Mitsui, A. Okui, T. Miki, and N. Yamaguchi Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate The Prostate 54 2003 299 305
15. T. Nakamura, C. Stephan, A. Scorilas, G.M. Yousef, K. Jung, and E.P. Diamandis Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues Urology 61 2003 1042 1046
16. E.P. Diamandis, A. Okui, S. Mitsui, Luo Liu-Ying, A. Soosaipillai, and L. Grass Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma Cancer Res 62 2002 295 300
17. C. Borgono, S. Fracchioli, G.M. Yousef, I.A. Rigault de la Longrais, Luo Liu-Ying, and A. Soosaipillai Favorable prognostic value of tissue human kallikrein 11 (hk11) in patients with ovarian carcinoma Int J Cancer 106 2003 605 610
18. E.P. Diamandis, C.A. Borgono, A. Scorilas, N. Harbeck, J. Dorn, and M. Schmitt Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients Clin Biochem 37 2004 823 829
19. A. Scorilas, C.A. Borgono, N. Harbeck, J. Dorn, B. Schmalfeldt, and M. Schmitt Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker J Clin Oncol 22 2004 678 685
20. M. Talieri, E.P. Diamandis, D. Gourgiotis, K. Mathioudaki, and A. Scorilas Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma Thromb Haemost 91 2004 180 186
21. C. Stephan, G.M. Yousef, A. Scorilas, K. Jung, M. Jung, and G. Kristiansen Quantitative analysis of kallikrein 15 gene expression in prostatic tissue J Urol 169 2003 361 364
22. G.M. Yousef, C. Stephan, A. Scorilas, M.A. Ellatif, K. Jung, and G. Kristiansen Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues Prostate 56 2003 287 292
23. G.M. Yousef, A. Scorilas, T. Nakamura, M.A. Ellatif, R. Ponzone, and N. Biglia The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer Breast Cancer Res Tr 78 2003 149 158
24. A. Chang, G.M. Yousef, A. Scorilas, L. Grass, P. Sismondi, and R. Ponzone Human Kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favorable prognosis in breast cancer Br J Cancer 86 2002 1457 1464
25. G.M. Yousef, A. Scorilas, K. Jung, L. Aschworth, and E.P. Diamandis The new human kallikrein gene KLK15 is up-regulated in prostate cancer J Biol Chem 276 2001 53 61
26. C.V. Obiezu, E.J. Giltay, A. Magklara, A. Scorilas, L.J. Gooren, and H. Yu Dramatic suppression of serum prostate specific antigen and human glandular kallikrein by anti-androgens in male to female transsexuals J Urol 163 2000 802 805
27. C. Obiezu, E. Giltay, A. Magklara, A. Scorilas, H. Yu, and L. Gooren Serum prostate specific antigen is significantly elevated after testosterone administration in female to male transsexuals Clin Chem 46 2000 859 862
28. M.A. Cobleigh, C.L. Vogel, D. Tripathy, N.J. Robert, S. Scholl, and L. Fehrenbacher Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease J Clin Oncol 17 1999 2639 2648
29. S.M. Sedlacek, and K.B. Horowitz The role of progestins and progesterone receptors in the treatment of breast cancer Steroids 44 1984 467 484
30. P.M. Ravdin, S. Green, T.M. Dorr, W.L. McGuire, C. Fabian, and R.P. Pugh Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study J Clin Oncol 10 1992 1284 1291
31. N.J. Bundred Prognostic and predictive factors in breast cancer Cancer Treat Rev 27 2001 137 142